Bristol-Myers Squibb acquires exclusive license from Novo Nordisk for autoimmune diseases discovery research
Bristol-Myers Squibb Company (NYSE:BMY) today announced the company has signed an agreement with Novo Nordisk under which Bristol-Myers Squibb will acquire an... Read More